Pedro Perez: This New PE Guideline Gives Practical Clues on Risk, Evaluation, and Care Pathways
Pedro Perez, Vascular Consultant – PERT and VTE Program Builder at Argon Medical Devices, Inc., shared on LinkedIn:
”Major progress in acute pulmonary embolism (PE) care!
The first joint American Heart Association (AHA) and American College of Cardiology (ACC) clinical guideline on acute PE highlights just how critical prompt diagnosis and treatment are to saving lives transforming how clinicians assess and manage this often-silent, life-threatening condition.
This new guideline introduces a practical clinical classification system to guide care, outlines risk factors clinicians should watch for, and provides clear recommendations on evaluation, treatment strategies, and follow-up care — no matter the care setting.
For the PE community, especially patients and their families affected by this condition, these changes mean:
- Faster, more accurate diagnosis
- More personalized, evidence-based treatment
- Better long-term outcomes and follow-up support
I’m encouraged to see the clinical community align around best practices that can make meaningful differences for patients and caregivers alike.
This is a big step forward in improving care and saving lives. ”
Stay updated with Hemostasis Today.
-
May 29, 2026, 13:49Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk